Ruth Langley

11PUBLICATIONS
96CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingPharmacogenomicsDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 26, 2026
The role of DNA mismatch repair status in oesophagogastric cancer treated with perioperative chemotherapy: evidence from the MRC ST03 and OE05 trials.

|Jun 17, 2024
Hit it hard: qualitative patient perspectives on the optimisation of immune checkpoint inhibition.

Sophie Merrick, Hannah L Rush, Susanna Daniels

|Dec 20, 2023
Stroma AReactive Invasion Front Areas (SARIFA) improves prognostic risk stratification of perioperative chemotherapy treated oesophagogastric cancer patients from the MAGIC and the ST03 trial.

Bianca Grosser, Jake Emmerson, Nic G Reitsam

|Jul 07, 2023
Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial.

Nalinie Joharatnam-Hogan, Duaa Hatem, Fay H Cafferty

|Jul 25, 2022
Docetaxel for Nonmetastatic Prostate Cancer: Long-Term Survival Outcomes in the STAMPEDE Randomized Controlled Trial.

Nicholas D James, Fiona C Ingleby, Noel W Clarke

|Jun 07, 2022
Radiotherapy to the prostate for men with metastatic prostate cancer in the UK and Switzerland: Long-term results from the STAMPEDE randomised controlled trial.

Chris C Parker, Nicholas D James, Christopher D Brawley

Pageof 2

Frequent Collaborators

6 joint publications

Matthew R Sydes

5 joint publications

Duncan Gilbert

5 joint publications

Mahesh Parmar

5 joint publications

Nicholas D James